Search results
Council Post: The Impending Talent Evolution That Organizations Face
Forbes· 11 hours agoOver the past few years, we've seen immense changes within the business landscape—the Great...
These celebrities are lined up to speak at N.J. college commencements
NJ.com· 2 hours agoA 1990s television star, a YouTube celebrity and a founder of a legendary music group are among the...
These NFL draft Day 3 fits can address 49ers' glaring needs
NBC Sports BayArea via Yahoo Sports· 6 days agoTrent Williams and Aaron Banks anchored the left side with strong performances in 2023, while the...
Rithm Capital (RITM) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoAs we go forward, we look forward -- as we go forward, we will look to increase our scale in our...
Buffett Rules Out ‘Eye-Popping’ Returns. But Investors Aren’t Listening.
The Wall Street Journal· 1 day agoBerkshire would be ready to pay any big losses that arise from its insurance business. The cash also...
Alligator weary? A word about real estate, 1031 tax exchanges and DSTs | Retire on Track
Herald-Tribune via Yahoo Finance· 4 days agoIt started as a hobby and now simply holds anchor for portfolio diversification purposes. The real...
Unveiling Carvana Co (CVNA)'s Value: Is It Really Priced Right?
Guru Focus· 15 hours agoThis analysis aims to delve into whether Carvana Co's current market price truly reflects its intrinsic value as calculated by the GF Value. Carvana Co operates a robust e-commerce platform ...
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss...
Fortune· 5 hours agoIndianapolis-based Eli Lilly (no. 142 on the Fortune 500) is the maker of Mounjaro, classified as Type 2 diabetes drug but which has led to weight loss among patients, and Zepbound, an obesity ...
Biden Cancels $6 Billion in Debt for Grads of Failed Art Institutes
PYMNTS.com· 2 days agoThe White House has forgiven $6.1 billion in loans for Art Institutes graduates. “The Art Institutes...
After April Showers, Will Markets Flower?
Forbes· 11 hours agoQ1 was great for markets. April was...not. So naturally, investors are wondering if this is just a “pause that refreshes” or a worrisome sign of more trouble to come.